JPS6360760B2 - - Google Patents

Info

Publication number
JPS6360760B2
JPS6360760B2 JP53073828A JP7382878A JPS6360760B2 JP S6360760 B2 JPS6360760 B2 JP S6360760B2 JP 53073828 A JP53073828 A JP 53073828A JP 7382878 A JP7382878 A JP 7382878A JP S6360760 B2 JPS6360760 B2 JP S6360760B2
Authority
JP
Japan
Prior art keywords
ser
ala
asn
glu
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53073828A
Other languages
English (en)
Japanese (ja)
Other versions
JPS549224A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS549224A publication Critical patent/JPS549224A/ja
Publication of JPS6360760B2 publication Critical patent/JPS6360760B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069Ser-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP7382878A 1977-06-20 1978-06-20 Novel peptide derivative and process for preparing same Granted JPS549224A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77584 1977-06-20

Publications (2)

Publication Number Publication Date
JPS549224A JPS549224A (en) 1979-01-24
JPS6360760B2 true JPS6360760B2 (ru) 1988-11-25

Family

ID=19728618

Family Applications (2)

Application Number Title Priority Date Filing Date
JP7382878A Granted JPS549224A (en) 1977-06-20 1978-06-20 Novel peptide derivative and process for preparing same
JP62122684A Granted JPS6372671A (ja) 1977-06-20 1987-05-21 新規n,s−ジ置換(r)−システイン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP62122684A Granted JPS6372671A (ja) 1977-06-20 1987-05-21 新規n,s−ジ置換(r)−システイン誘導体

Country Status (18)

Country Link
EP (1) EP0000330B1 (ru)
JP (2) JPS549224A (ru)
AT (1) AT364095B (ru)
AU (1) AU525005B2 (ru)
CA (1) CA1139305A (ru)
DD (1) DD139257A5 (ru)
DE (1) DE2860893D1 (ru)
DK (1) DK275178A (ru)
ES (3) ES470961A1 (ru)
FI (1) FI781933A (ru)
GR (1) GR71681B (ru)
IE (1) IE46957B1 (ru)
IL (1) IL54950A (ru)
NO (1) NO148921C (ru)
NZ (1) NZ187611A (ru)
PL (3) PL207766A1 (ru)
PT (1) PT68188A (ru)
ZA (1) ZA783504B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0641776A3 (en) * 1993-09-08 1997-05-02 Takeda Chemical Industries Ltd Thioglycerol derivatives.

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014815A3 (de) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen
DE3485094D1 (de) * 1983-01-25 1991-10-31 Ciba Geigy Ag Neue peptidderivate.
FR2546164B1 (fr) * 1983-05-16 1987-07-17 Centre Nat Rech Scient Nouveaux derives de peptides, leur preparation et leur application comme inhibiteurs de l'elastase
DE3546150A1 (de) * 1985-06-24 1987-01-22 Hoechst Ag Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
DE3522638A1 (de) * 1985-06-25 1987-01-08 Diamalt Ag Neue somatostatin-derivate
FR2611205B1 (fr) * 1987-02-20 1990-03-02 Serbio Dipeptides, procede de preparation et utilisation dans le dosage de proteases
AU626797B2 (en) * 1987-09-08 1992-08-13 Albany Medical College Immunogenic composites capable of selectively inducing antibody production, pharmaceutical compositions employing the same and method of selectively inducing antibody production
DE4119856A1 (de) * 1991-06-17 1992-12-24 Hoechst Ag N-acyl-s-(2-hydroxyalkyl)-cysteine, deren herstellung sowie deren verwendung als zwischenprodukte zur herstellung von synthetischen immunadjuvantien und synthetischen impfstoffen
DK0548024T3 (da) * 1991-12-19 1997-01-27 Ciba Geigy Ag Aminosulfonsyrederivater samt fremgangsmåder til deres fremstilling
AU666789B2 (en) * 1992-12-28 1996-02-22 Takeda Chemical Industries Ltd. 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof
EP0604945A1 (en) 1992-12-28 1994-07-06 Takeda Chemical Industries, Ltd. TAN-1511, its derivatives, production and use thereof
GB9930591D0 (en) * 1999-12-23 2000-02-16 Univ London Component for vaccine
DE10048840A1 (de) * 2000-10-02 2002-04-11 Biotechnolog Forschung Gmbh Verwendung von Lipopeptiden oder Lipoproteinen zur Behandlung von Lungeninfektionen und -tumoren
FR2816060A1 (fr) * 2000-10-27 2002-05-03 Pf Medicament Procede d'identification de nouvelles molecules se liant au recepteur lox et utilisation de ces molecules
ES2539490T3 (es) 2005-06-13 2015-07-01 Cleveland Biolabs, Inc. Métodos para proteger frente a apoptosis usando lipopéptidos
MX2008001183A (es) * 2005-07-25 2008-04-11 Therimunex Llc Peptidil diacilgliceridos.
DE102016005550A1 (de) 2016-05-09 2017-11-09 Emc Microcollections Gmbh Adjuvans zur lnduzierung einer zellulären lmmunantwort
US10907764B2 (en) * 2017-11-06 2021-02-02 Crown Equipment Corporation Industrial vehicle layover system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2706490A1 (de) 1976-02-20 1977-08-25 Ciba Geigy Ag Neue carbonsaeureester

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0641776A3 (en) * 1993-09-08 1997-05-02 Takeda Chemical Industries Ltd Thioglycerol derivatives.

Also Published As

Publication number Publication date
PL207766A1 (pl) 1979-11-19
JPS6372671A (ja) 1988-04-02
AT364095B (de) 1981-09-25
CA1139305A (en) 1983-01-11
ATA445178A (de) 1981-02-15
FI781933A (fi) 1978-12-21
ZA783504B (en) 1979-06-27
ES478717A1 (es) 1979-12-16
AU525005B2 (en) 1982-10-14
DD139257A5 (de) 1979-12-19
PT68188A (de) 1978-07-01
JPS549224A (en) 1979-01-24
ES478718A1 (es) 1979-12-16
EP0000330B1 (de) 1981-08-05
ES470961A1 (es) 1980-03-01
DK275178A (da) 1978-12-21
JPS641466B2 (ru) 1989-01-11
IE46957B1 (en) 1983-11-16
IL54950A0 (en) 1978-08-31
DE2860893D1 (en) 1981-11-05
IL54950A (en) 1983-10-31
NO148921C (no) 1984-01-11
EP0000330A1 (de) 1979-01-24
GR71681B (ru) 1983-06-21
PL216740A1 (ru) 1980-05-19
PL216739A1 (ru) 1980-05-19
IE781227L (en) 1978-12-20
NZ187611A (en) 1981-07-13
NO148921B (no) 1983-10-03
NO782138L (no) 1978-12-21
AU3723078A (en) 1980-01-03

Similar Documents

Publication Publication Date Title
JPS6360760B2 (ru)
US4439425A (en) Peptide derivatives
FI83524B (fi) Foerfarande foer framstaellning av farmakologiskt verkande n-/n-alkanoyl-s-(2,3-dialkanoyloxi-propyl) kysteinyl/-peptider.
RU2060998C1 (ru) Способ получения пептидов, пептиды, иммуномодулирующая композиция и способ регуляции недостаточной или избыточной функции т-клеток у пациента
CZ129694A3 (en) Novel peptide derivatives
CA2301687A1 (en) Phenethylamine derivatives
NZ196261A (en) Lipophilic muramyl-peptides; peptide intermediates; pharmaceutical compositions; feedstuffs and feedstuff additives comprising antibiotic and muramyl-peptide
US5688771A (en) Lipophilic oligopeptides with immunomodulating activity
US4390528A (en) Tuftsinyl-tuftsin
AU721261B2 (en) Peptide inhibitors of hematopoietic cell proliferation
US3801561A (en) Derivatives of salmon thyrocalcitonin
JPH0796557B2 (ja) 新規ペプチド、その製法およびそれを含有する医薬組成物
GB2185486A (en) Conjugate of alpha-melanotropin with p-L-sarcolysine (melphalan)
CA1247084A (en) Peptide process for preparation thereof and use thereof
US5656601A (en) Acylated splenopentins, methods for their synthesis and their use
EP0050856B1 (en) New peptide, process for its preparation and pharmaceutical composition containing it
HU199878B (en) Process for producing acylated splenopentynes and pharmaceutical compositions comprising such compounds as active ingredient
KR860000518B1 (ko) 펩타이드의 제조방법
JPS633000A (ja) ペプチド誘導体類及びそれらの製造方法
JPH06107681A (ja) ペプチド誘導体
JPS6045600A (ja) グルコサミニルムラミルテトラペプチド誘導体